First Tracks Biotherapeutics (TRAX) has an average rating of Buy and mean price target of $43.88, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $42.92, Change: $+7.40, Percent Change: +20.83%